Clovis Oncology Denmark ApS: Financial statements 2022
CVR: 38721682
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Clovis Oncology Denmark ApS (CVR 38721682) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,268,076 and a net result of DKK -683,391 compared with DKK 46,336 the year before. That is a decrease of 17.6% compared with the year before. Equity in the 2022 report amounted to DKK -384,329. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,268,076
- Profit/Loss
- DKK -683,391
- Equity
- DKK -384,329
- Total Assets
- DKK 1,640,048
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.3M | -683K | -384K | 1 |
| 2021 | - | 1.5M | 46K | 299K | 1 |
| 2020 | - | 1.7M | 44K | 253K | 1 |
| 2019 | - | 1.9M | 65K | 209K | 1 |
| 2018 | - | 4.5M | 21K | 50K | 2 |
Official annual report
Keep an eye on Clovis Oncology Denmark ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Clovis Oncology Denmark ApS has published its annual report for 2021. Gross profit came to DKK 1,539,039, and the net result was DKK 46,336.
As of June 15, 2022, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Clovis Oncology Denmark ApS.
About Clovis Oncology Denmark ApS
Clovis Oncology Denmark ApS was a Danish company of the type Anpartsselskab based in Allerød, founded in 2017. The company has been dissolved on 5 June 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -1,276,497 and a net result of DKK -1,290,249 compared with DKK -683,391 the year before. Equity in the 2023 report amounted to DKK -356,205.